About this Event
Radiotherapy contributes to around 40% of cancer cures and benefits as many as half of all patients with a cancer diagnosis. However, radioresistance remains a pervasive cause of treatment failure and adds to the burden of treatment-related toxicity.
Efforts to sensitise tumours to radiation have met with limited success. Given this, researchers are increasingly instead focussing on how tumours adapt to and evolve with radiotherapy as a means to finding new ways to overcome resistance.
This seminar will bring together leading researchers, with talks spanning clinical, wet lab and computational approaches to studying radiotherapy-related tumour evolution.
Join us for an afternoon of compelling science followed by Christmas drinks and a chance to network with colleagues.
Agenda
🕑: 04:00 PM - 05:45 PM
Chairs: Gunjan Katyal & Ashley Nicholls, CRUK RadNet Cambridge
🕑: 04:00 PM - 04:05 PM
Welcome
Host: Charlotte Coles, CRUK RadNet Cambridge
🕑: 04:05 PM - 04:25 PM
Evolution and radiotherapy resistance in head and neck cancer
Host: Ben O'Leary, CRUK Institute of Cancer Research
🕑: 04:25 PM - 04:45 PM
Lineage tracing to understand how cancers evolve and adapt to radiotherapy
Host: Chris Jones, CRUK RadNet Cambridge
🕑: 04:45 PM - 05:05 PM
An NFI-regulated,pre-existing transcriptional programme underlies glioblastoma
Host: Jamie Dean, CRUK RadNet City of London
🕑: 05:05 PM - 05:25 PM
Adaptive radioresistance in urological cancers: a new paradigm
Host: Ananya Choudhury, CRUK RadNet Manchester
🕑: 05:25 PM - 05:45 PM
Panel discussion and close
Host: Chris Jones, CRUK RadNet Cambridge
🕑: 05:45 PM - 06:30 PM
Networking drinks
Event venue & nearby stays
Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, United Kingdom